Global and regional burden of first-ever ischaemic and haemorrhagic stroke during 1990-2010: findings from the Global Burden of Disease Study 2010.

Krishnamurthi RV, Feigin VL, Forouzanfar MH, Mensah GA, Connor M, Bennett DA, Moran AE, Sacco RL, Anderson LM, Truelsen T, O'Donnell M, Venketasubramanian N, Barker-Collo S, Lawes CM, Wang W, Shinohara Y, Witt E, Ezzati M, Naghavi M, Murray C, Global Burden of Diseases, Injuries, Risk Factors Study 2010 (GBD 2010), GBD Stroke Experts Group. · 2013

Read Global and regional burden of first-ever ischaemic and haemorrhagic stroke during 1990-2010: findings from the Global Burden of Disease Study 2010. by Krishnamurthi RV, Feigin VL, Forouzanfar MH, Mensah GA, Connor M, Bennett DA, Moran AE, Sacco RL, Anderson LM, Truelsen T, O'Donnell M, Venketasubramanian N, Barker-Collo S, Lawes CM, Wang W, Shinohara Y, Witt E, Ezzati M, Naghavi M, Murray C, Global Burden of Diseases, Injuries, Risk Factors Study 2010 (GBD 2010), GBD Stroke Experts Group. (2013) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/europmc-pmc4181351.txt.

Introduction

Rita V. Krishnamurthi, Valery L. Feigin, and a large Global Burden of Disease team measured world stroke burden in The Lancet Global Health in 2013. Stroke splits into two kinds: ischaemic, from a blocked vessel, and haemorrhagic, from a burst one. Planners need to know how each kind is shifting by region.

Drawing on 119 studies, the team estimated first-ever stroke counts, deaths, and lost healthy years for 1990, 2005, and 2010. The raw number of people struck rose sharply, up 37 percent for ischaemic and 47 percent for haemorrhagic stroke, mostly in poorer countries. Most of the burden fell on people under 75 in those regions. The authors argue prevention plans must fit each region's stroke mix rather than copy rich-country models.

Catalog record

CREATORKrishnamurthi RV, Feigin VL, Forouzanfar MH, Mensah GA, Connor M, Bennett DA, Moran AE, Sacco RL, Anderson LM, Truelsen T, O'Donnell M, Venketasubramanian N, Barker-Collo S, Lawes CM, Wang W, Shinohara Y, Witt E, Ezzati M, Naghavi M, Murray C, Global Burden of Diseases, Injuries, Risk Factors Study 2010 (GBD 2010), GBD Stroke Experts Group.
YEAR2013
COLLECTIONPAPERS
FORMATTXT
FILE SIZE35 KB
LICENSECC BY 4.0
RIGHTSCC BY
SOURCEEurope PMC

Source: https://europepmc.org/articles/PMC4181351

Browse the full library · About the Tower of Babel

Full text

The opening of the work, from the library's hosted text:

Global and regional burden of first-ever ischaemic and haemorrhagic stroke during 1990–2010: findings from the Global Burden of Disease Study 2010 By Rita V Krishnamurthi, Valery L Feigin, Mohammad H Forouzanfar, George A Mensah, Myles Connor, Derrick A Bennett, Andrew E Moran, Ralph L Sacco, Laurie M Anderson, Thomas Truelsen, Martin O’Donnell, Narayanaswamy Venketasubramanian Published in: The Lancet. Global health DOI: 10.1016/S2214-109X(13)70089-5 ABSTRACT Summary Background The burden of ischaemic and haemorrhagic stroke varies between regions and over time. With differences in prognosis, prevalence of risk factors, and treatment strategies, knowledge of stroke pathological type is important for targeted region-specific health-care planning for stroke and could inform priorities for type-specific prevention strategies. We used data from the Global Burden of Diseases, Injuries, and Risk Factors Study 2010 (GBD 2010) to estimate the global and regional burden of first-ever ischaemic and haemorrhagic stroke during 1990–2010. Methods We searched Medline, Embase, LILACS, Scopus, PubMed, Science Direct, Global Health Database, the WHO library, and regional databases from 1990 to 2012 to identify relevant studies published between 1990 and 2010. We applied the GBD 2010 analytical technique (DisMod-MR) to calculate regional and country-specific estimates for ischaemic and haemorrhagic stroke incidence, mortality, mortality-to-incidence ratio, and disability-adjusted life-years (DALYs) lost, by age group (aged <75 years, ≥75 years, and in total) and country income level (high-income and low-income and middle-income) for 1990, 2005, and 2010. Findings We included 119 studies (58 from high-income countries and 61 from low-income and middle-income countries). Worldwide, the burden of ischaemic and haemorrhagic stroke increased significantly between 1990 and 2010 in terms of the absolute number of people with incident ischaemic and haemorrhagic stroke (37% and 47% increase, respectively), number of deaths (21% and 20% increase), and DALYs lost (18% and 14% increase). In the past two decades in high-income countries, incidence of ischaemic stroke reduced significantly by 13% (95% CI 6–18), mortality by 37% (19–39), DALYs lost by 34% (16–36), and mortality-to-incidence ratios by 21% (10–27). For haemorrhagic stroke, incidence reduced significantly by 19% (1–15), mortality by 38% (32–43), DALYs lost by 39% (32–44), and mortality-to-incidence ratios by 27% (19–35). By contrast, in low-income and middle-income countries, we noted a significant increase of 22% (5–30) in incidence of haemorrhagic stroke and a 6% (–7 to 18) non-significant increase in the incidence of ischaemic stroke. Mortality rates for ischaemic stroke fell by 14% (9–19), DALYs lost by 17% (–11 to 21%), and mortality-to-incidence ratios by 16% (–12 to 22). For haemorrhagic stroke in low-income and middle-income countries, mortality rates reduced by 23% (–18 to 25%), DALYs lost by 25% (–21 to 28), and mortality-to-incidence ratios by 36% (–34 to 28). Interpretation Although age-standardised mortality rates for ischaemic and haemorrhagic stroke have decreased in the past two decades, the absolute number of people who have these stroke types annually, and the number with related deaths and DALYs lost, is increasing, with most of the burden in low-income and middle-income countries. Further study is needed in these countries to identify which subgroups of the population are at greatest risk and who could be targeted for preventive efforts. INTRODUCTION Investigation of stroke burden by its major pathological types, and study of their secular trends in different regions of the world, is important for targeted region-specific health-care planning in stroke (eg, estimation of resources needed to care for patients with stroke, by type) and can inform priorities for type-specific prevention strategies. These data are also important for improving understanding of the health consequences and patterns of epidemiological transitions reported worldwide. Findings from systematic reviews suggest that low-income and middle-income countries have a greater proportion of haemorrhagic stroke than do high-income countries,1 that geographical variation is high in the incidence of major pathological types of stroke,1 and that no substantial changes have taken place in the incidence of haemorrhagic stroke in the past three decades.2,3 However, no detailed and systematic comprehensive estimates have been made of the global and regional incidence, case-fatality, disability-adjusted life-years (DALYs) lost, and secular trends of incidence of ischaemic or haemorrhagic stroke, especially for low-income and middle-income countries.4–6 We report estimates from the Global Burden of Diseases, Injuries, and Risk Factors Study (GBD 2010) for incidence, mortality, mortality-to-incidence ratio, and DALYs lost in ischaemic or haemorrhagic stroke in all 21 regions of the world7 in 1990, 2005, and 2010. METHODS Systematic literature review We did a systematic literature review to establish the review process. The search strategy and selection criteria and have been described elsewhere.8,9 We assessed pathological types of stroke for studies that used head CT or MRI within the first 2 weeks of stroke onset, or for those in which brain autopsy findings for confirmation of type were available for at least 70% of stroke cases. We categorised pathological stroke types into two groups—ischaemic and haemorrhagic (intracerebral haemorrhage and subarachnoid haemorrhage combined). We included all age groups in the analysis. We analysed only first-ever stroke events. Calculation of incidence, mortality, and DALYs lost We have described our statistical analysis strategies elsewhere and in a companion report in The Lancet.8,9 Briefly, we applied the GBD 2010 analytical technique (DisMod-MR) to calculate regional and country-specific estimates of incidence and mortality per 100 000 person-years for ischaemic and haemorrhagic stroke, and of DALYs lost per 100 000 people, by age group (<20 years, 20–64 years, 65–74 years, ≤75 years, total) and level of country income (high and low and middle) for 1990, 2005, and 2010. Disease modelling For modelling of mortality for ischaemic and haemorrhagic stroke, we selected a set of relevant covariates (appendix) and assumed a plausible direction of effect on the basis of existing published work. The ensemble approach combined different model results developed with different combinations of covariates and statistical approaches.10 In a separate process—the CODCorrect process11—the number of deaths from ischaemic or haemorrhagic stroke were rescaled to total the overall number of deaths (mortality envelope) for a country, sex, and age group. This process also ensured that the sum of cardiovascular disease deaths was equal to all deaths from cardiovascular disease (modelled independently). The appendix shows the estimates before and after correction for stroke deaths. We report age-standardised incidence and mortality rates per 100 000 person-years and estimates of DALYs lost per 100 000 people with the direct method of standardisation and WHO’s standard population as a reference.12 Additionally, we calculated mortality-to-incidence ratio for each region and country as an indicator of the success or failure of stroke management strategies in a particular region (ratio numbers were based on the total number of incident cases and deaths). We estimated p values on the basis of 1000 draws of the posterior distribution of each statistic. Because some posterior distributions deviated significantly from normal, 2·5 and 97·5 percentiles of the draws were reported as the lower and upper bounds of the uncertainty interval for the statistic. We calculated 95% CIs for all rates. Role of the funding source The sponsor of the study had no role in study design, data collection, data analysis, data interpretation, or writing of the report. The Writing and GBD Global Analysis Group had full access to all the data in the study and had final responsibility for the decision to submit for publication. RESULTS Characteristics of studies

Read the complete text